Satisfaction and Compliance of Risedronate in PMO

Summary

Compare subject satisfaction of once a week dosing of 35 mg Risedronate to once daily dosing of 5 mg Risedronate in postmenopausal osteoporotic women. Secondary objectives are to measure compliance (50 % drug taken), and persistence.

Timeline

Start

2003-10

Primary completion

—

Completion

—

Drugs

Indications